Tyche Industries FY26 net profit falls 44% to ₹693.71 lakh

1 min read     Updated on 29 May 2026, 12:33 AM
scanx
Reviewed by
Suketu GScanX News Team
AI Summary

Tyche Industries Limited reported a 44.1% decline in net profit to ₹693.71 lakh for FY26, with revenue falling to ₹5,363.40 lakh. The board recommended a final dividend of ₹3.50 per share and re-appointed auditors for the upcoming fiscal year.

powered bylight_fuzz_icon
41540576

*this image is generated using AI for illustrative purposes only.

Tyche Industries Limited reported a 44.1% decline in net profit to ₹693.71 lakh for the financial year ended March 31, 2026, compared to ₹1,240.71 lakh in the previous year, primarily due to lower revenue. The board of directors, in its meeting held on May 28, 2026, approved the audited financial results and recommended a final dividend of ₹3.50 per equity share for the fiscal year, subject to the approval of shareholders at the ensuing Annual General Meeting.

For the quarter ended March 31, 2026, the company recorded a net profit of ₹115.35 lakh, a decrease from ₹182.21 lakh in the quarter ended December 31, 2025, and an increase from ₹94.43 lakh in the corresponding quarter of the previous year. Revenue from operations for the quarter stood at ₹1,619.53 lakh, compared to ₹1,057.93 lakh in the preceding quarter and ₹1,236.51 lakh in the year-ago period. Total income for the quarter was ₹1,915.11 lakh.

The company's total expenses for FY26 amounted to ₹5,339.20 lakh, lower than the ₹5,617.25 lakh reported in FY25. Profit before tax for the year declined to ₹946.44 lakh from ₹1,671.40 lakh in the previous fiscal. The statutory auditors, M/S P.S.N. Ravishanker & Associates, issued an unmodified opinion on the audited financial results.

Financial Performance for FY26

The following table outlines the key financial metrics for Tyche Industries for the year ended March 31, 2026, compared to the prior year:

Particulars Year Ended 31/03/2026 (₹ in Lakhs) Year Ended 31/03/2025 (₹ in Lakhs)
Revenue from Operations 5,363.40 6,547.13
Total Income 6,285.63 7,288.65
Total Expenses 5,339.20 5,617.25
Profit Before Tax 946.44 1,671.40
Net Profit 693.71 1,240.71
Earnings Per Share (Basic) 6.70 12.19

Operational Highlights and Board Decisions

The company operates exclusively in the APIs segment. Sales for the year included exports of ₹4,841.33 lakh, while exports for the quarter ended March 31, 2026, were ₹1,450.78 lakh. The board also re-appointed Mr. Sativada Venkat Rao as the Cost Auditor and M/S K Srinivas & Associates as the Internal Auditor for the financial year 2026-27. The meeting commenced at 16:30 P.M. and concluded at 20:15 P.M.

Historical Stock Returns for Tyche Industries

1 Day5 Days1 Month6 Months1 Year5 Years
+0.47%+2.86%+12.67%+14.84%-2.15%-37.88%

What specific factors drove the decline in revenue, and does management expect this trend to reverse in FY27?

How will the company maintain its dividend payout policy given the significant drop in net profit and EPS?

What strategies are being implemented to mitigate the impact of lower revenue on future profitability?

Tyche Industries Limited Receives ANVISA Brazil GMP Certificate for Kakinada Manufacturing Facility

1 min read     Updated on 24 Mar 2026, 05:51 PM
scanx
Reviewed by
Radhika SScanX News Team
AI Summary

Tyche Industries Limited has received a Certificate of GMP Compliance from ANVISA, Brazil's health regulatory agency, for its manufacturing facility in Kakinada, Andhra Pradesh. The certificate, announced on March 24, 2026, is valid for two years from March 16, 2026, to March 16, 2028. This achievement follows the successful completion of a GMP inspection by ANVISA Brazil, which was previously announced on September 11, 2025, representing a significant regulatory milestone for the pharmaceutical manufacturer.

powered bylight_fuzz_icon
35900517

*this image is generated using AI for illustrative purposes only.

Tyche Industries Limited has successfully obtained a Certificate of GMP Compliance from ANVISA, Brazil's health regulatory agency, marking a significant regulatory achievement for the pharmaceutical manufacturer. The company announced this development through a formal communication to BSE Limited on March 24, 2026, under Regulation 30 of the SEBI Listing Obligations and Disclosure Requirements.

Certificate Details and Validity

The GMP compliance certificate pertains to Tyche Industries' manufacturing facility located in Kakinada, Andhra Pradesh. The certification demonstrates the facility's adherence to Good Manufacturing Practice standards as required by Brazilian regulatory authorities.

Parameter: Details
Issuing Authority: ANVISA, Brazil
Facility Location: Kakinada, Andhra Pradesh
Certificate Validity: March 16, 2026 to March 16, 2028
Validity Period: 2 years
Announcement Date: March 24, 2026

Regulatory Process Timeline

The certificate issuance follows a structured regulatory process that began with an inspection by ANVISA Brazil. The company had previously informed stakeholders about the successful completion of the GMP inspection on September 11, 2025. The time gap between the inspection completion and certificate receipt reflects the thorough evaluation process conducted by the Brazilian regulatory authority.

Manufacturing Facility Information

The certified facility is strategically located at Door No. 6-223, Sarpavaram, Kakinada. This manufacturing unit has now achieved compliance with Brazilian GMP standards, which are recognized internationally for their stringent quality requirements. The certification validates the facility's manufacturing processes, quality control systems, and overall operational standards.

Regulatory Compliance Framework

The announcement was made in accordance with Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. Company Secretary and Compliance Officer Pradosh Ranjan Jena signed the official communication, ensuring proper disclosure to market participants and regulatory authorities.

Company Background

Tyche Industries Limited operates from its registered office located at H.No. C 21/A, Road No. 9, Film Nagar, Jubilee Hills, Hyderabad. The company, incorporated in 1998 with CIN L72200TG1998PLC029809, maintains its manufacturing operations in Kakinada while headquartering its corporate functions in Hyderabad.

Historical Stock Returns for Tyche Industries

1 Day5 Days1 Month6 Months1 Year5 Years
+0.47%+2.86%+12.67%+14.84%-2.15%-37.88%

What specific pharmaceutical products does Tyche Industries plan to export to Brazil following this GMP certification?

How will this ANVISA certification impact Tyche Industries' revenue projections and market expansion strategy in Latin America?

Will Tyche Industries seek similar GMP certifications from other international regulatory bodies to expand its global footprint?

More News on Tyche Industries

1 Year Returns:-2.15%